JF
GLUE icon

Jump Financial’s Monte Rosa Therapeutics GLUE Stock Holding History

Jump Financial’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Sell
34,900
-149,622
-81% -$2.83M 0.01% 1260
2026
Q1 		$3.04M Buy
+184,522
New +$3.53M 0.04% 497
2025
Q1 		– Sell
-154,842
Closed -$1.07M – 1754
2024
Q4 		$1.07M Buy
+154,842
New +$1.16M 0.02% 731
2024
Q3 		– Sell
-16,338
Closed -$61.1K – 1822
2024
Q2 		$61.1K Sell
16,338
-560
-3% -$2.85K ﹤0.01% 1679
2024
Q1 		$119K Buy
+16,898
New +$100K ﹤0.01% 1769
2022
Q4 		– Sell
-18,200
Closed -$149K – 1741
2022
Q3 		$149K Buy
+18,200
New +$167K 0.01% 1399

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's GLUE Position: Q2 2026 in Review

Jump Financial reduced its Monte Rosa Therapeutics (GLUE) stake by 81% in Q2 2026, selling an estimated $2.83M and leaving 34,900 shares worth $845K. The position accounts for 0.01% of the portfolio, ranked #1260.

Jump Financial first reported a position in GLUE in Q3 2022 and has held it in 6 quarters since. The position peaked at $3.04M in Q1 2026. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Jump Financial held 34,900 shares of Monte Rosa Therapeutics worth $845K as of Q2 2026.
  • Jump Financial sold 149,622 Monte Rosa Therapeutics shares in Q2 2026, an estimated $2.83M.
  • Monte Rosa Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1260 holding.
  • Jump Financial first reported a position in Monte Rosa Therapeutics in Q3 2022 and has held it in 6 quarters since.
  • Jump Financial's Monte Rosa Therapeutics position peaked at $3.04M in Q1 2026.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.